MiRNA-155 was overexpressed in breast cancer and downregulated the repressor SOCS1 (suppressor of cytokine signaling 1), resulting in an aberrant activation of STAT3 signaling pathway [127]. Here, SOCS1 is linked to breast carcinoma.